Terns Pharmaceuticals Inc (TERN) — Net Asset Momentum
Terns Pharmaceuticals Inc (TERN) recorded a net asset momentum of 35.4% as of December 2024, with net assets of $345.87 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Terns Pharmaceuticals Inc book value and equity for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Terns Pharmaceuticals Inc Net Asset Momentum (2018–2024)
This chart tracks Terns Pharmaceuticals Inc's year-over-year net asset growth across 7 annual reporting periods from 2018 to 2024. The most recent momentum reading is +35.4%, with net assets of $345.87 Million USD as of December 2024. Check TERN tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Net Asset History for Terns Pharmaceuticals Inc (2018–2024)
The table below shows the complete annual net asset history for Terns Pharmaceuticals Inc from 2018 to 2024, covering 7 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Terns Pharmaceuticals Inc stock valuation.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $345.87 Million | $363.93 Million | $18.06 Million | ▲ +35.4% |
| 2023 | $255.37 Million | $268.52 Million | $13.15 Million | ▼ -7.8% |
| 2022 | $276.94 Million | $287.03 Million | $10.08 Million | ▲ +72.8% |
| 2021 | $160.30 Million | $168.07 Million | $7.77 Million | ▲ +133.7% |
| 2020 | $68.59 Million | $92.29 Million | $23.70 Million | ▲ +274.3% |
| 2019 | $18.32 Million | $23.90 Million | $5.58 Million | ▼ -74.6% |
| 2018 | $72.23 Million | $89.07 Million | $16.84 Million | — |